Liver-Specific Angiotensinogen Suppression: An Old Yet Novel Target for Blood Pressure Control Through RAS Inhibition?

Hypertension Research - United Kingdom
doi 10.1038/hr.2014.54
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Glial-Specific Ablation of Angiotensinogen Lowers Arterial Pressure in Renin and Angiotensinogen Transgenic Mice

American Journal of Physiology - Regulatory Integrative and Comparative Physiology
Physiology
2005English

Novel Pyridazinone Inhibitors for Vascular Adhesion Protein-1 (VAP-1): Old Target–New Inhibition Mode

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2013English

5T4 Oncofoetal Glycoprotein: An Old Target for a Novel Prostate Cancer Immunotherapy

Oncotarget
Oncology
2017English

Rapid Intervention Through Telephone Encounters for Blood Pressure Control by Residents in an Outpatient Resident Clinic

Cureus
2018English

Novel Antidotes for Target Specific Oral Anticoagulants

Experimental Hematology and Oncology
Cancer ResearchOncologyHematology
2015English

Blood Pressure and Old Age

American Heart Journal
Cardiovascular MedicineCardiology
1943English

Blood Pressure Control for Diabetic Retinopathy

Sao Paulo Medical Journal
Medicine
2015English

Metformin: An Old Taboo Yet a New Friend for Targeted Glucose Control in Critically Ill Patients

Advances in Bioscience and Clinical Medicine
2016English

Targeting Ras Signaling Through Inhibition of Carboxyl Methylation: An Unexpected Property of Methotrexate

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy